ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 45 of 48 for:    gum disease | NIH

Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03366142
Recruitment Status : Suspended (Enrollment paused until PI investigates if patient lesions may be due to study drug.)
First Posted : December 8, 2017
Last Update Posted : October 19, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )